Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04341311
Title Phase I Study of Marizomib + Panobinostat for Children With DIPG (DIPG)
Acronym DIPG
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Age Groups: adult | child
Covered Countries USA

No variant requirements are available.